# Inflammation and Daily Life Study

> **NCT03771612** · EARLY_PHASE1 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 144 (actual)

## Conditions studied

- Inflammation

## Interventions

- **DRUG:** Naproxen
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03771612
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-09
- **Primary completion:** 2023-11-09
- **Final completion:** 2024-06-21
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2025-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03771612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03771612, "Inflammation and Daily Life Study". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT03771612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*